Academic Articles & Research Papers

Unrecognized importance of hawking prey capture tactics in a tropical plunge-diving seabird.

Schiffmiller AW, Braman CA, Johns M, Maxwell S et al. • Biology letters (2026)

PMC PMC Public Access (View-Only) DOI: 10.1098/rsbl.2026.0292 PMC: PMC13730644

View Article » Original Source ↗

Discordance of PD-L1 expression between primary and paired metastatic non-small cell lung cancer: a systematic review and meta-analysis.

Zhang L, Gao Y, Wang X, Gu Y et al. • Frontiers in immunology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fimmu.2026.1942041 PMC: PMC13728784

View Article » Original Source ↗

Spatial ligand-receptor circuits in osteosarcoma: immune resistance in bone and lung niches.

Qiu Y, Deng S, Zhou J, Tan Q et al. • Frontiers in immunology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fimmu.2026.1932933 PMC: PMC13729368

View Article » Original Source ↗

Concurrent loss of RB1 facilitates EGFR-TKI resistance in EGFR-mutant lung cancer by modulating histone crotonylation.

Chen S, Wang X, Xuan Q, Liu C et al. • Acta pharmaceutica Sinica. B (2026)

PMC PMC Public Access (View-Only) DOI: 10.1016/j.apsb.2026.08.007 PMC: PMC13730233

View Article » Original Source ↗

Shengjiang San suppresses C5a/C5aR1-mediated neutrophil activation and NET formation to alleviate acute lung injury.

Zhang D, Li X, Zeng J, Cheng D et al. • Frontiers in pharmacology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fphar.2026.1955412 PMC: PMC13730836

View Article » Original Source ↗

Reproductive factors and lung cancer risk in never-smoking women: a prospective cohort study.

Nie Y, Liang D, Jin Y, Gao M et al. • BMC cancer (2026)

PMC PMC Public Access (View-Only) DOI: 10.1186/s12885-026-16429-w PMC: PMC13733033

View Article » Original Source ↗

Cost-effectiveness of first-line pembrolizumab monotherapy in PD-L1-high metastatic non-small cell lung cancer in Australia: evidence from trials and real-world practice.

Teppala S, Koo J, Tan ECK, Clarke S et al. • International journal of clinical pharmacy (2026)

PMC PMC Public Access (View-Only) DOI: 10.1007/s11096-026-02202-3 PMC: PMC13731505

View Article » Original Source ↗

NAPRT loss promotes lung tumor initiation and growth through AKT signaling independently of NAD(+) biosynthesis.

Oh MJ, Jang JY, Jeon Y, Kim GC et al. • Molecular oncology (2026)

PMC PMC Public Access (View-Only) DOI: 10.1002/1878-0261.70330 PMC: PMC13613957

View Article » Original Source ↗

Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae among Ugandan Adolescents and Adults Vulnerable to HIV.

Ouellette M, Burns N, Ying R, Nakabuye I et al. • Sexually transmitted diseases (2026)

PMC PMC Public Access (View-Only) DOI: 10.1097/OLQ.0000000000002405 PMC: PMC13734341

View Article » Original Source ↗

Gramicidin Inhibits Lung Cancer Metastasis by Suppressing the ABL-MMP9 Signaling Axis.

Li X, Chen L • Journal of biochemical and molecular toxicology (2026)

PMC PMC Public Access (View-Only) DOI: 10.1002/jbt.71156 PMC: PMC13734286

View Article » Original Source ↗

Climate change as a modifier of paediatric lung-function trajectories.

Drummond D, Renz HE, Beri C, Rosa MJ et al. • European respiratory review : an official journal of the European Respiratory Society (2026)

PMC PMC Public Access (View-Only) DOI: 10.1183/16000617.0222-2026 PMC: PMC13732408

View Article » Original Source ↗

Integrated analysis identifies an aging-related prognostic signature for lung adenocarcinoma.

Zhang R, Chen X, Li N, Peng M • BMC cancer (2026)

PMC PMC Public Access (View-Only) DOI: 10.1186/s12885-026-16534-w PMC: PMC13732848

View Article » Original Source ↗

Influenza-associated acute respiratory deterioration fulfilling acute exacerbation criteria in hospitalized patients with interstitial lung disease: a single-center retrospective cohort study.

Nakahama H, Ogawa K, Miyamoto A, Kurosaki A et al. • BMC pulmonary medicine (2026)

PMC PMC Public Access (View-Only) DOI: 10.1186/s12890-026-04561-z PMC: PMC13733016

View Article » Original Source ↗

Large-scale plasma proteomics identifies proteins and pathways associated with incident interstitial lung disease.

Kang Z, Zhu Y, Zhang J, Zhu C et al. • Frontiers in immunology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fimmu.2026.1962219 PMC: PMC13731268

View Article » Original Source ↗

Case Finding for COPD in Nottingham and District (C FIND COPD). A Pilot Study of Uptake, Acceptability and Diagnostic Yield in a One-Stop Assessment Following Lung Cancer Screening.

Burzic A, Hamrouni M, Porte J, Gupta A et al. • International journal of chronic obstructive pulmonary disease (2026)

PMC PMC Public Access (View-Only) DOI: 10.2147/COPD.S634297 PMC: PMC13733389

View Article » Original Source ↗

Biochanin A Induces Cuproptosis and Inhibits Lung Metastasis in triple-negative Breast Cancer.

Zhang L, Duan Y, Pu S, Chen P et al. • Oncology research (2026)

PMC PMC Public Access (View-Only) DOI: 10.32604/or.2026.084760 PMC: PMC13732377

View Article » Original Source ↗

Epigenetic Silencing of ZNF471 Contributes to Osimertinib Resistance in Lung Adenocarcinoma: β-Hydroxybutyrate Associates with ZNF471 Re-Expression and Reduced Resistance-Associated Phenotypes.

Feng D, Yan H, Ni Q, Peng Z et al. • Oncology research (2026)

PMC PMC Public Access (View-Only) DOI: 10.32604/or.2026.087712 PMC: PMC13732338

View Article » Original Source ↗

Cardiovascular biomarker phenotype associated with immune checkpoint inhibitor therapy in patients with non-small cell lung cancer: an exploratory blood transcriptome study.

Ziemska-Legięcka J, Żeber-Lubecka N, Borucka M, Kaczmarska D et al. • Frontiers in immunology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fimmu.2026.1972440 PMC: PMC13733417

View Article » Original Source ↗

A RALGEF inhibitor suppresses lung cancer stem cell development and tumorigenesis.

Jigo R, Clark GJ • The Journal of biological chemistry (2026)

PMC PMC Public Access (View-Only) DOI: 10.1016/j.jbc.2026.113564 PMC: PMC13734910

View Article » Original Source ↗

Multiomics analysis identifies RNASET2 as a potential candidate target associated with lung adenocarcinoma.

Shi Y, Yang J, Cai F, Huang J et al. • The Journal of international medical research (2026)

PMC PMC Public Access (View-Only) DOI: 10.1177/03000605261488089 PMC: PMC13735068

View Article » Original Source ↗